Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FR06A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,236
Award facts
- Contract value 100% obligated
- $37,236.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for $37,236.39 to supply RINVOQ ER 15 mg tablets (30-count units) under contract number 4570381768. The delivery order, which was not set-aside and competitively awarded, is scheduled for completion by January 2, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare systems worldwide.
RINVOQ ER (upadacitinib extended-release) is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions, representing the type of specialty pharmaceutical products that AmerisourceBergen regularly supplies to the federal government through its prime vendor relationships. As a major pharmaceutical distributor, AmerisourceBergen fulfills critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, delivering an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains in support of military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FR06A?
SPE2DR26FR06A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FR06A worth?
The government has obligated $37,236 on SPE2DR26FR06A.
Is contract SPE2DR26FR06A an order under another contract?
Yes. SPE2DR26FR06A is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR06A competed?
The extent of competition for SPE2DR26FR06A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award